Cargando…

Positive correlation between plasma PCSK9 and tissue factors levels in patients with angiographically diagnosed coronary artery disease and diabetes mellitus

BACKGROUND: Pro-protein convertase subtilisin/kexin type 9 (PCSK9) is a secreted protein that influences plasma levels of low-density lipoprotein cholesterol (LDL-C). Both oxidized LDL and tissue factor (TF) contributed to the development of prothrombotic state. The present study aims to explore the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Mei, Li, Yan-Fang, Guo, Yan-Ging, Chen, Meng-Meng, Jiang, Zhi-Li, Song, Jun-Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science Press 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921543/ https://www.ncbi.nlm.nih.gov/pubmed/27403140 http://dx.doi.org/10.11909/j.issn.1671-5411.2016.04.002

Ejemplares similares

Serum Levels of PCSK9 Are Associated with Coronary Angiographic Severity in Patients with Acute Coronary Syndrome
por: Bae, Kwi-Hyun, et al.
Publicado: (2018)

Relation of plasma PCSK9 levels to lipoprotein subfractions in patients with stable coronary artery disease
por: Xu, Rui-Xia, et al.
Publicado: (2014)

Plasma PCSK9 Levels Are Elevated with Acute Myocardial Infarction in Two Independent Retrospective Angiographic Studies
por: Almontashiri, Naif A. M., et al.
Publicado: (2014)

Systemic Correlates of Angiographic Coronary Artery Disease
por: Nunes, José Pedro L., et al.
Publicado: (2009)

PCSK9 Inhibitors Reduce PCSK9 and Early Atherogenic Biomarkers in Stimulated Human Coronary Artery Endothelial Cells
por: Zulkapli, Rahayu, et al.
Publicado: (2023)

Letter: Serum Levels of PCSK9 Are Associated with Coronary Angiographic Severity in Patients with Acute Coronary Syndrome (Diabetes Metab J 2018;42:207-14)
por: Kim, Jin Hwa
Publicado: (2018)

Response: Serum Levels of PCSK9 Are Associated with Coronary Angiographic Severity in Patients with Acute Coronary Syndrome (Diabetes Metab J 2018;42:207-14)
por: Kim, Sung Woo, et al.
Publicado: (2018)

Angiographic Correlation and Synergistic Effect of Coronary Artery Stenosis and Cerebral Artery Stenosis: A Retrospective Study
por: Tao, Hua, et al.
Publicado: (2014)

PCSK9 positively correlates with plasma sdLDL in community-dwelling population but not in diabetic participants after confounder adjustment
por: Liu, Yan, et al.
Publicado: (2019)

The association between circulatory, local pancreatic PCSK9 and type 2 diabetes mellitus: The effects of antidiabetic drugs on PCSK9
por: Lu, Fengyuan, et al.
Publicado: (2023)

The predictive utility of circulating PCSK9 levels on diabetes mellitus
por: Peng, Jia, et al.
Publicado: (2021)

PCSK9 Gene E670G Polymorphism and Coronary Artery Disease: An Updated Meta-Analysis of 5,484 Subjects
por: Li, Yan-yan, et al.
Publicado: (2020)

Pcsk9 is associated with severity of coronary artery lesions in male patients with premature myocardial infarction
por: Gao, Jing, et al.
Publicado: (2021)

Relationship between lipid profiles and plasma total homocysteine, cysteine and the risk of coronary artery disease in coronary angiographic subjects
por: Xiao, Yunjun, et al.
Publicado: (2011)

Association of PCSK9 plasma levels with metabolic patterns and coronary atherosclerosis in patients with stable angina
por: Caselli, Chiara, et al.
Publicado: (2019)

Correlation Between Circulating PCSK9 Levels and Gestational Diabetes Mellitus in a Chinese Population
por: Wu, Yiming, et al.
Publicado: (2022)

Impaired Fibrinolysis in Angiographically Documented Coronary Artery Disease
por: Fernandes, Adriano Basques, et al.
Publicado: (2015)

Calculation of Coronary Angiographic Total Blush in Patients with Coronary Artery Disease and its Prognostic Implication
por: Gai, Jing-Jing, et al.
Publicado: (2015)

Platelet-Derived PCSK9 Is Associated with LDL Metabolism and Modulates Atherothrombotic Mechanisms in Coronary Artery Disease
por: Petersen-Uribe, Álvaro, et al.
Publicado: (2021)

Plasma levels of Elabela are associated with coronary angiographic severity in patients with acute coronary syndrome
por: DU, Sheng-Li, et al.
Publicado: (2020)

Dual-source CT coronary angiographic evaluation of coronary artery fistulas
por: LIU, MIN, et al.
Publicado: (2014)

Predictive Value of Plasma Big Endothelin-1 in Adverse Events of Patients With Coronary Artery Restenosis and Diabetes Mellitus: Beyond Traditional and Angiographic Risk Factors
por: Ma, Yue, et al.
Publicado: (2022)

PON-1 Activity and Plasma 8-Isoprostane Concentration in Patients with Angiographically Proven Coronary Artery Disease
por: Kuchta, Agnieszka, et al.
Publicado: (2016)

Polymorphisms of rs2483205 and rs562556 in the PCSK9 gene are associated with coronary artery disease and cardiovascular risk factors
por: Gai, Min-Tao, et al.
Publicado: (2021)

Correlation between serum levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) and atherogenic lipoproteins in patients with coronary artery disease
por: Nozue, Tsuyoshi, et al.
Publicado: (2016)

Effect of PCSK9 inhibitor on lipoprotein particles in patients with acute coronary syndromes
por: Li, Tingting, et al.
Publicado: (2021)

Dietary protein and plasma total homocysteine, cysteine concentrations in coronary angiographic subjects
por: Xiao, Yunjun, et al.
Publicado: (2013)

Can metformin stabilize PCSK9 level in stable coronary artery disease patients treated with statins?
por: Shek, Aleksandr B., et al.
Publicado: (2019)

Risk factor reduction in progression of angiographic coronary artery disease
por: Lai, Hoang M., et al.
Publicado: (2012)

Coronary artery ectasia: prevalence, angiographic characteristics and clinical outcome
por: Willner, Nadav Asher, et al.
Publicado: (2020)

Coronary Artery Plaque Regression by a PCSK9 Antibody and Rosuvastatin in Double-heterozygous Familial Hypercholesterolemia with an LDL Receptor Mutation and a PCSK9 V4I Mutation
por: Shirahama, Ryo, et al.
Publicado: (2018)

Clinical and Coronary Angiographic Findings of 400 Korean Adults with Coronary Artery Disease
por: Lee, Woong-Ku, et al.
Publicado: (1987)

Zinc and copper levels are not correlated with angiographically-defined coronary artery disease in sudanese patients
por: Lutfi, Mohamed F., et al.
Publicado: (2015)

PCSK9 inhibition potentiates cancer immune checkpoint therapy
por: Liu, Xinjian, et al.
Publicado: (2020)

PCSK9 inhibitors for acute coronary syndrome: the era of early implementation
por: Chen, Hongzhen, et al.
Publicado: (2023)

Impact of currently prescribed lipid-lowering drugs on plasma PCSK9 concentration: single or in combination study in rats
por: Zhang, Yan, et al.
Publicado: (2014)

Plasma PCSK9 levels are significantly modified by statins and fibrates in humans
por: Mayne, Janice, et al.
Publicado: (2008)

FOURIER & PCSK9 RNAi: Towards enhancing durability and efficacy of PCSK9 inhibitors
por: Hassan, Mohamed
Publicado: (2017)

The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol
por: Seidah, Nabil G.
Publicado: (2017)

Coronary Artery Calcium Score to Refine the Use of PCSK9i in Asymptomatic Individuals: A Multicohort Study
por: Cainzos‐Achirica, Miguel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i65rv6b73a2o6033382qj0fmtc